← Browse by Condition
Medical Condition
erdheim chester disease
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT05915208
Recruiting
Histiocytic Disorder Follow-up Study
Enrollment
6,000 pts
Location
United States
Sponsor
University of Alabama at Birmi...
NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK